Pub. Date : 2020 Jan
PMID : 31778074
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Dose-escalation trial of the ALK, MET & ROS1 inhibitor, crizotinib, in patients with advanced cancer. | Crizotinib | ROS proto-oncogene 1, receptor tyrosine kinase | Homo sapiens |